Viewing Study NCT05603156


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-02 @ 1:54 PM
Study NCT ID: NCT05603156
Status: UNKNOWN
Last Update Posted: 2022-11-02
First Post: 2022-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module